Emerging Markets
GMO Emerging Markets ex-China Fund
Last updated: 2026-09-03
The Verdict
GMO Emerging Markets ex-China Fund charges an expense ratio of 0.68%. On a $100,000 portfolio, that's $680 per year in fees, and it scales with the amount invested. Supreme.PM's decoded model tracked it at only 49% correlation over the measured period, so it should not be treated as a substitute for this fund, for a flat monthly subscription that does not change with portfolio size.
Expense Ratio
0.68%
Star Rating
5/ 5
Market Beta
1.11
Model Correlation
49%
Sharpe Ratio
1.07
Max Drawdown
17.10%
Supreme.PM Cost
Flat monthly subscription
Not a percentage of your assets
Performance
Performance comparison — 1Y: Fund 51.1% vs Model 25.2%; 3Y: Fund 103.5% vs Model 198.1%.
Alpha After Fees
Supreme.PM's model shows 49% correlation with GMO Emerging Markets ex-China Fund over the measured period. That is weak tracking: the model does not reproduce this fund's return pattern, and a negative figure means it moved in the opposite direction.
Fee Analysis
GMO Emerging Markets ex-China Fund charges 0.68% of assets annually. Supreme.PM charges a flat monthly subscription instead, so its cost does not rise as a portfolio grows.
Data sources: Refinitiv Lipper, SEC EDGAR Filings, Supreme.PM Analytics
Past performance does not guarantee future results. Model returns are backtested and may not reflect actual trading conditions.
Related
Emerging Markets Category
Browse all Emerging Markets funds
Emerging Markets Rankings
Top-rated Emerging Markets funds
Our Methodology
How we decode fund strategies
JPMorgan Emerging Markets Equity Fund
4-star rated
Invesco EQV Emerging Markets All Cap Fund
3-star rated
Emerging Markets Growth Fund
3-star rated
GMO Emerging Markets Fund
3-star rated
VanEck Emerging Markets Fund
2-star rated
Frequently Asked Questions
What is the expense ratio of GMO Emerging Markets ex-China Fund?
GMO Emerging Markets ex-China Fund has an expense ratio of 0.68%, charged as a percentage of the amount invested. Supreme.PM's decoded model is offered for a flat monthly subscription instead.
How does Supreme.PM replicate GMO Emerging Markets ex-China Fund?
Supreme.PM builds a transparent, rules-based model of listed securities designed to track this fund's return profile. Over the measured period it tracked the fund poorly, at 49% correlation. The model is published in full, so its positions are visible rather than disclosed with a delay.
What are the risks of fund replication?
While our models aim for high correlation, they may not perfectly match the fund's returns due to timing differences in rebalancing, transaction costs, and disclosure delays. Backtested results may not reflect future performance.
Get This Strategy
Start investing with Supreme.PM's decoded model and save on fees while capturing similar returns.